【结 构 式】 |
【分子编号】29753 【品名】2-bromo-N,N-dimethylacetamide 【CA登记号】 |
【 分 子 式 】C4H8BrNO 【 分 子 量 】166.01766 【元素组成】C 28.94% H 4.86% Br 48.13% N 8.44% O 9.64% |
合成路线1
该中间体在本合成路线中的序号:(II)The reaction of p-hydrophenylacetic acid (I) with N,N-dimethylbromoacetamide (II) by means of triethylamine in reftuxing acetonitrile gives N,N-dimethylcarbamoylmethyl-p-hydroxyphenylacetate (III), which is then condensed with p-guanidinobenzoyl chloride (IV) [obtained from the corresponding acid p-guanidinobenzoic acid (V) and thionyl chloride] in pyridine.
【1】 Fujii, S.; Uegai, Y.; Watanabe, T.; Kayama, N. (Ono Pharmaceutical Co., Ltd.); Guanidinobenzoic acid derivatives. DE 2548886; FR 2289181; GB 1472700; JP 76054530; US 4021472 . |
【2】 Fujii, S.; et al. (Ono Pharmaceutical Co., Ltd.); Guanidinobenzoic acid derivatives and antiplasmin agents and remedies for pancreas diseases containing the said guanidinobensolc acid derivatives. JP 52089640 . |
【3】 Castaner, J.; Serradell, M.N.; Hashimoto, K.; Camostat Mesylate. Drugs Fut 1985, 10, 11, 897. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 18430 | 2-(4-Hydroxyphenyl)acetic acid; 4-Hydroxyphenylacetic acid | 156-38-7 | C8H8O3 | 详情 | 详情 |
(II) | 29753 | 2-bromo-N,N-dimethylacetamide | C4H8BrNO | 详情 | 详情 | |
(III) | 29754 | 2-(dimethylamino)-2-oxoethyl 2-(4-hydroxyphenyl)acetate | C12H15NO4 | 详情 | 详情 | |
(IV) | 29755 | 4-[[amino(imino)methyl]amino]benzoic acid | C8H9N3O2 | 详情 | 详情 | |
(V) | 22548 | 4-[[amino(imino)methyl]amino]benzoyl chloride | C8H8ClN3O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(X)The benzyl-protected 2-(2-hydroxyethyl)phenol (I) was brominated in HOAc to give (II). Lithiation of aryl bromide (II) followed by in situ condensation of the resulting organolithium derivative (III) with diethyl oxalate under -95 C furnished the keto ester (IV). Subsequent ketone reduction by NaBH4 afforded hydroxy ester (V), which was further hydrolyzed to the mandelic acid derivative (VI). The condensation of racemic acid (VI) with (S)-2-amino-7-hydroxytetraline (VII) gave rise to a diastereomeric mixture of hydroxy amides from which the desired (S,R)-diastereoisomer (VIII) was isolated by column chromatography. Reduction of the amide function of (VIII) using borane-dimethyl sulfide complex yielded the amino alcohol (IX). Alkylation of the phenolic hydroxyl group of (IX) with 2-bromo-N,N-dimethylacetamide (X) provided the corresponding (aryloxy)acetamide (XI). Then, hydrogenolysis of the benzyl protecting groups over Pd/C furnished the target compound, which was finally isolated as the corresponding sulfate salt.
【1】 Kitazawa, M.; Okazaki, K.; Tamai, T.; Saito, M.; Muranaka, H.; Tanaka, N.; Kobayahi, H.; Kikuchi, K. (Kissei Pharmaceutical Co., Ltd.); 3,4-Disubstd. phenylethanolaminotetralincarboxamide derivs.. EP 0882704; US 6133266; WO 9730023 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 50674 | 1-(benzyloxy)-2-[2-(benzyloxy)ethyl]benzene; benzyl 2-[2-(benzyloxy)ethyl]phenyl ether | C22H22O2 | 详情 | 详情 | |
(II) | 50675 | benzyl 2-(benzyloxy)-5-bromophenethyl ether; 1-(benzyloxy)-2-[2-(benzyloxy)ethyl]-4-bromobenzene | C22H21BrO2 | 详情 | 详情 | |
(III) | 50676 | [4-(benzyloxy)-3-[2-(benzyloxy)ethyl]phenyl]lithium | C22H21LiO2 | 详情 | 详情 | |
(IV) | 50677 | ethyl 2-[4-(benzyloxy)-3-[2-(benzyloxy)ethyl]phenyl]-2-oxoacetate | C26H26O5 | 详情 | 详情 | |
(V) | 50678 | ethyl 2-[4-(benzyloxy)-3-[2-(benzyloxy)ethyl]phenyl]-2-hydroxyacetate | C26H28O5 | 详情 | 详情 | |
(VI) | 50679 | 2-[4-(benzyloxy)-3-[2-(benzyloxy)ethyl]phenyl]-2-hydroxyacetic acid | C24H24O5 | 详情 | 详情 | |
(VII) | 32819 | (7S)-7-amino-5,6,7,8-tetrahydro-2-naphthalenol | C10H13NO | 详情 | 详情 | |
(VIII) | 50680 | (2R)-2-[4-(benzyloxy)-3-[2-(benzyloxy)ethyl]phenyl]-2-hydroxy-N-[(2S)-7-hydroxy-1,2,3,4-tetrahydro-2-naphthalenyl]ethanamide | C34H35NO5 | 详情 | 详情 | |
(IX) | 50681 | (7S)-7-[((2R)-2-[4-(benzyloxy)-3-[2-(benzyloxy)ethyl]phenyl]-2-hydroxyethyl)amino]-5,6,7,8-tetrahydro-2-naphthalenol | C34H37NO4 | 详情 | 详情 | |
(X) | 29753 | 2-bromo-N,N-dimethylacetamide | C4H8BrNO | 详情 | 详情 | |
(XI) | 50682 | 2-([(7S)-7-[((2R)-2-[4-(benzyloxy)-3-[2-(benzyloxy)ethyl]phenyl]-2-hydroxyethyl)amino]-5,6,7,8-tetrahydro-2-naphthalenyl]oxy)-N,N-dimethylacetamide | C38H44N2O5 | 详情 | 详情 |